All photos courtesy of Mary Lou Grace Robison. Main image: “Crumbling,” published in The Ignatian Literary Magazine Mary Lou Grace Robison only picked up…
Creating a roadmap is critical to navigating the challenges that come with dementia. Being Patient sat down with Bree Baldwin, aging life care manager…
Now under review, the drug pimavanserin may become the first FDA-approved treatment for dementia-related psychosis. Roughly 2.4 million Americans experience symptoms of dementia-related psychosis,…
For families including those with loved ones who have dementia, navigating the system of conservatorship can be daunting. In November 2020, a Los Angeles…
Being Patient spoke with Kim Natovitz, associate at TriBridge Partners, about the costs of dementia care services and ways to navigate insurance plans for medical treatment and long-term care.
Dr. Eric B. Larson, a senior investigator at Kaiser Permanente Washington Health Research Institute, discusses how meaningful the act of reminiscence can be for older…
Trouble swallowing can be a slippery slope to a number of other health issues. Being Patient spoke to two experts in speech, language, eating…
Shopping for a loved one with Alzheimer’s or dementia? You might see fidget quilts, fidget boxes, even fidget mittens on holiday gift lists this…
The pandemic has left many college students with more time on their hands and fewer job opportunities. As another impact of the pandemic has…
While Biogen’s experimental Alzheimer’s treatment aducanumab faced yet another snag recently in its convoluted path toward FDA approval, other drugs companies are catching up:…
The first ever commercial Alzheimer’s blood test is on the market. It’s big progress. Some experts have reservations because it hasn’t yet secured FDA…
“CRISPR-Cas9 is … a readily available, highly specific, and cost-effective technology that has unquestionably changed what is possible in the investigation and potential treatment…
In an unexpected twist, the advisory committee that convened today on the experimental Alzheimer’s treatment aducanumab overwhelmingly said that drugmaker Biogen has failed to…
Before Alex Trebek’s cancer diagnosis, he grappled another health concern: age-related cognitive decline, leading him to seek out cognitive testing for dementia. Beloved quiz show…
A prima ballerina with Alzheimer’s disease remembers Tchaikovsky’s “Swan Lake;” details of her past as a dancer remain a mystery. The ability of music…
Alzheimer’s and memory care expert Christy Turner explains cognitive screening: why it’s important, how it works, and how the current media frenzy around Joe…
“He’d waited decades to argue his innocence. She was a judge who believed in second chances. No one knew she suffered from Alzheimer’s.” The…
By: Mary Lou Grace Robison As told to: Niki Chen All photos courtesy of Mary Lou Grace Robison Mary Lou Grace Robison, granddaughter of…
Being Patient readers share their own stories about navigating life with “Alzheimer’s genes.” Alzheimer’s disease affects one in 10 people over the age of…
It has been more than eight months since I stepped inside a grocery store. Women and men who I don’t know comb the aisles…
In a surprising turn of events, the Advisory Committee of experts on Biogen’s experimental Alzheimer’s drug aducanumab recommended against FDA approval of the drug…